Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Case of Merkel cell carcinoma in a patient with pre-existing ILD
Rohan Maniar
, Michaela Anderson
, Bret Taback
, Shaheer Khan
, Diana McDonnell
, Anjali Saqi
, George W. Niedt
, Richard Carvajal
Research output
:
Contribution to journal
›
Article
›
peer-review
1
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Case of Merkel cell carcinoma in a patient with pre-existing ILD'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Interstitial Lung Disease
100%
Merkel Cell Carcinoma
100%
Multidisciplinary Approach
40%
Durable Response
40%
Recent Advances
20%
Close Monitoring
20%
Active Surveillance
20%
Local Recurrence
20%
Complete Response
20%
Immune Checkpoint Blockade
20%
Distant Metastasis
20%
Successful Treatment
20%
Neuroendocrine Tumor
20%
New Diagnosis
20%
Programmed Death-ligand 1 (PD-L1)
20%
Pembrolizumab
20%
Cytotoxic Chemotherapy
20%
PD-1 Inhibitor
20%
Medical Issues
20%
Radiographical
20%
PD-1 Inhibition
20%
Immune Checkpoint Blockade Treatment
20%
Medicine and Dentistry
Interstitial Lung Disease
100%
Merkel Cell Carcinoma
100%
Recurrent Disease
40%
Immunotherapy
40%
Immune Checkpoint Blockade
40%
Distant Metastasis
20%
Neuroendocrine Tumor
20%
Programmed Death 1 Receptor
20%
Cytotoxic Chemotherapy
20%
Pembrolizumab
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Interstitial Lung Disease
100%
Merkel Cell Carcinoma
100%
Immunotherapy
40%
Recurrent Disease
40%
Distant Metastasis
20%
Programmed Death 1 Receptor
20%
Pembrolizumab
20%
Cytotoxic Chemotherapy
20%
Neuroendocrine Tumor
20%
Diseases
20%
Immunology and Microbiology
Merkel Cell
100%
Immunotherapy
40%
Immune Checkpoint Blockade
40%
Programmed Death 1 Receptor
20%
Pembrolizumab
20%